STAAR Surgical Company (STAA)

NASDAQ: STAA · IEX Real-Time Price · USD
42.70
+0.08 (0.19%)
At close: May 17, 2024, 4:00 PM
42.36
-0.34 (-0.80%)
After-hours: May 17, 2024, 7:30 PM EDT
0.19%
Market Cap 2.10B
Revenue (ttm) 326.24M
Net Income (ttm) 15.30M
Shares Out 49.13M
EPS (ttm) 0.31
PE Ratio 137.74
Forward PE 65.24
Dividend n/a
Ex-Dividend Date n/a
Volume 219,003
Open 42.82
Previous Close 42.62
Day's Range 42.06 - 43.71
52-Week Range 26.66 - 65.07
Beta 0.81
Analysts Buy
Price Target 46.86 (+9.74%)
Earnings Date May 7, 2024

About STAA

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are prima... [Read more]

Sector Healthcare
Founded 1982
Employees 1,115
Stock Exchange NASDAQ
Ticker Symbol STAA
Full Company Profile

Financial Performance

In 2023, STAA's revenue was $322.42 million, an increase of 13.37% compared to the previous year's $284.39 million. Earnings were $21.35 million, a decrease of -46.18%.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for STAA stock is "Buy." The 12-month stock price forecast is $46.86, which is an increase of 9.74% from the latest price.

Price Target
$46.86
(9.74% upside)
Analyst Consensus: Buy
Stock Forecasts

News

STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ast...

11 days ago - Business Wire

STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ast...

17 days ago - Business Wire

STAAR Surgical to Report First Quarter Results on May 7, 2024

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ast...

19 days ago - Business Wire

What's going on with STAAR Surgical shares?

STAAR Surgical (NASDAQ: STAA) received an upgrade from William Blair on Friday. The stock has been moved from Market Perform to Outperform status.

6 weeks ago - Invezz

STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ast...

6 weeks ago - Business Wire

STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL) for myopia, asti...

6 weeks ago - Business Wire

STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ast...

2 months ago - Business Wire

STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmat...

2 months ago - Business Wire

STAAR Surgical to Participate in Two Upcoming Investor Conferences

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ast...

2 months ago - Business Wire

STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ast...

2 months ago - Business Wire

STAAR Surgical to Report Fourth Quarter Results on February 26, 2024

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ast...

3 months ago - Business Wire

STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ast...

4 months ago - Business Wire

STAAR Surgical Announces Preliminary Results for Fourth Quarter and Fiscal 2023

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL) for myopia, asti...

4 months ago - Business Wire

Lilian Zhou Appointed to STAAR Surgical Board of Directors

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmat...

5 months ago - Business Wire

STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmat...

6 months ago - Business Wire

STAAR Surgical Reports Third Quarter 2023 Results

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmat...

7 months ago - Business Wire

These healthcare stocks should come to life as boomers live their golden years

Baby boomers: Love ‘em or hate ‘em, the juggernaut generation changes every aspect of life it steamrolls through. Now it's doing the same to healthcare.

Other symbols: AZNZBH
7 months ago - Market Watch

STAAR Surgical to Report Third Quarter Results on November 1, 2023

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release fina...

7 months ago - Business Wire

STAAR Surgical Celebrates 30th Anniversary of Implantable Collamer® Lens (ICL)

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is celebrating the 30th anniversary of it...

7 months ago - Business Wire

Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL

LAKE FOREST, Calif. , Oct. 10, 2023 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is proud to announce a part...

7 months ago - PRNewsWire

STAAR Surgical to Ring Nasdaq Stock Market Closing Bell Following Vision 2026 Investor Day on September 14, 2023

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, will host Vision 2026, the Company's inve...

8 months ago - Business Wire

STAAR Surgical to Host “Vision 2026” Investor Day on September 14, 2023

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will host an in-p...

9 months ago - Business Wire

Dolby Laboratories Set to Join S&P MidCap 400; Staar Surgical to Join S&P SmallCap 600

NEW YORK , Aug. 17, 2023 /PRNewswire/ -- Dolby Laboratories Inc. (NYSE:DLB) will replace Staar Surgical Co. (NASD:STAA) in the S&P MidCap 400 and Staar Surgical will replace Urstadt Biddle Properties ...

Other symbols: DLB
9 months ago - PRNewsWire

STAAR Surgical to Participate in Upcoming Investor Conferences

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that management will part...

10 months ago - Business Wire

STAAR Surgical Reports Second Quarter 2023 Results

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the ...

10 months ago - Business Wire